Elevation Oncology, Inc. (NASDAQ:ELEV – Get Rating) – Analysts at SVB Leerink increased their Q2 2023 earnings per share estimates for Elevation Oncology in a note issued to investors on Monday, May 15th. SVB Leerink analyst A. Berens now anticipates that the company will post earnings of ($0.30) per share for the quarter, up from […]
Elevation Oncology, Inc. (NASDAQ:ELEV – Get Rating) was the recipient of a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 1,030,000 shares, a growth of 688.7% from the April 15th total of 130,600 shares. Based on an average daily trading volume, of 766,300 shares, […]
Elevation Oncology, Inc. (NASDAQ:ELEV – Get Rating) saw a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 123,200 shares, an increase of 135.6% from the March 15th total of 52,300 shares. Approximately 0.8% of the shares of the company are sold short. Based on […]
62,500 Shares in Elevation Oncology, Inc. (NASDAQ:ELEV) Purchased by Goldman Sachs Group Inc. etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.